Shingrix vial kits
Ended Awarded
- Contract number
- SPE2DB25FMZJB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,004
Award facts
- Contract value 100% obligated
- $10,003.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Shingrix vial kits valued at $10,003.60 by the Defense Logistics Agency on September 3, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and operates under a competitive, non-set-aside procurement. This award is a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. That parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply vaccines, specialty medications, and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency manages the Medical Supply Chain for the Department of Defense and utilizes prime vendor contracts like the SPE2DX to ensure efficient procurement of critical pharmaceutical products and vaccines for military medical facilities and personnel. Shingrix, a recombinant zoster vaccine, represents a key immunization product within the federal healthcare supply chain. AmerisourceBergen's role as a prime vendor demonstrates its established capability to meet federal procurement requirements through open competition and its consistent performance in delivering pharmaceutical commodities across multiple therapeutic domains to support defense health operations.
Quick answers
Who was awarded contract SPE2DB25FMZJB?
SPE2DB25FMZJB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FMZJB worth?
The government has obligated $10,004 on SPE2DB25FMZJB.
Is contract SPE2DB25FMZJB an order under another contract?
Yes. SPE2DB25FMZJB is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZJB competed?
The extent of competition for SPE2DB25FMZJB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award